Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Apr-24 7:27 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 18-Apr-24 | Gift | 14,164 | -- | -- | 9% 149.57K to 163.73K | |
| 19-Apr-24 7:27 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Apr-24 | Gift | 14,164 | -- | -- | (9%) 163.73K to 149.57K | |
| 02-Apr-24 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Apr-24 | Option Exercise | 4,000 | $10.03 | $40,120.00 | 3% 149.57K to 153.57K | |
| 02-Apr-24 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Apr-24 | Planned Option Sale | 4,000 | $58.66 | $234,640.00 | (3%) 153.57K to 149.57K | |
| 05-Mar-24 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-24 | Option Exercise | 6,000 | $10.03 | $60,180.00 | 4% 149.57K to 155.57K | |
| 05-Mar-24 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-24 | Planned Option Sale | 6,000 | $63.22 | $379,340.00 | (4%) 155.57K to 149.57K | |
| 13-Feb-24 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 1,431 | $67.77 | $96,974.40 | (< 1%) 151.0K to 149.57K | |
| 31-Jan-24 4:34 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 906 | $64.14 | $58,109.20 | (< 1%) 151.91K to 151.0K | |
| 23-Jan-24 6:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 3,551 | $65.00 | $230,801.00 | (2%) 155.46K to 151.91K | |
| 17-Jan-24 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 23,748 | -- | -- | 18% 133.94K to 157.69K | |
| 17-Jan-24 4:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 2,235 | $66.81 | $149,317.00 | (1%) 157.69K to 155.46K | |
| 01-Dec-23 4:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 30-Nov-23 | Option Exercise | 14,158 | $10.03 | $142,005.00 | 11% 133.94K to 148.1K | |
| 01-Dec-23 4:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 30-Nov-23 | Planned Option Sale | 14,158 | $54.73 | $774,884.00 | (10%) 148.1K to 133.94K | |
| 06-Jul-23 4:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jul-23 | Option Exercise | 6,779 | $10.03 | $67,993.40 | 5% 133.94K to 140.72K | |
| 06-Jul-23 4:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Jul-23 | Planned Option Sale | 6,779 | $89.97 | $609,928.00 | (5%) 140.72K to 133.94K | |
| 06-Jun-23 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Jun-23 | Option Exercise | 69,779 | $10.03 | $699,883.00 | 52% 133.94K to 203.72K | |
| 06-Jun-23 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Jun-23 | Planned Option Sale | 69,779 | $88.80 | $6,196,530.00 | (34%) 203.72K to 133.94K | |
| 03-May-23 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-May-23 | Gift | 20,000 | -- | -- | 15% 133.94K to 153.94K | |
| 03-May-23 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-May-23 | Gift | 20,000 | -- | -- | (13%) 153.94K to 133.94K | |
| 20-Apr-23 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Apr-23 | Gift | 36,232 | -- | -- | 27% 133.94K to 170.18K | |
| 20-Apr-23 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Apr-23 | Gift | 36,232 | -- | -- | (21%) 170.18K to 133.94K | |
| 22-Feb-23 6:42 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 11,683 | -- | -- | 9% 123.24K to 134.92K | |
| 22-Feb-23 6:42 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 974 | $58.50 | $56,979.00 | (< 1%) 134.92K to 133.94K | |
| 14-Feb-23 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 975 | $51.21 | $49,929.80 | (< 1%) 124.21K to 123.24K | |
| 30-Jan-23 5:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 551 | $52.77 | $29,076.30 | (< 1%) 124.76K to 124.21K | |
| 24-Jan-23 5:23 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 2,379 | $52.05 | $123,827.00 | (2%) 127.14K to 124.76K | |
| 17-Jan-23 8:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 27,488 | -- | -- | 28% 99.65K to 127.14K | |
| 17-Jan-23 8:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Disposition (other) | 3,750 | -- | -- | (4%) 103.4K to 99.65K | |
| 14-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 875 | $47.12 | $41,230.00 | (< 1%) 104.28K to 103.4K | |
| 01-Feb-22 6:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 650 | $38.59 | $25,083.50 | (< 1%) 104.93K to 104.28K | (15%) |
| 25-Jan-22 4:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 30,787 | -- | -- | 42% 74.14K to 104.93K | |
| 09-Jun-21 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 08-Jun-21 | Option Exercise | 39,880 | $10.03 | $399,996.00 | 116% 34.26K to 74.14K | |
| 11-Feb-21 4:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 858 | $47.72 | $40,943.80 | (2%) 35.12K to 34.26K | (19%) |
| 01-Feb-21 4:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 11,250 | -- | -- | 47% 23.87K to 35.12K | |
| 12-Feb-20 5:09 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Grant | 11,688 | -- | -- | 100% 11.7K to 23.39K | |
| 03-Sep-19 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Aug-19 | Market Purchase (Planned) | 11,699 | $29.71 | $347,630.00 | 100% 0 to 11.7K | 91% |